Evidence map›Paper›PMID 41959045›Full record

ArticlebioRxiv : the preprint server for biology2026

Molecular architecture of Influenza A virions.

Swetha Vijayakrishnan, Jack C Hirst, Sarah Cole, Svenja S Hester, Vattipally B Sreenu, Colin Loney, Wael Kamel, Roman Fischer, Terry K Smith, Ludovic Autin and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Swetha VijayakrishnanMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID 0000-0002-1895-1272
Jack C HirstMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID 0000-0003-4325-9867
Sarah ColeMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID 0000-0002-1318-967X
Svenja S HesterDiscovery Proteomics Facility, Nuffield Department of Medicine, University of Oxford, UK.ORCID 0000-0003-2420-9063
Vattipally B SreenuMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID 0000-0001-6673-4697
Colin LoneyMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID 0000-0002-0508-1781
Wael KamelMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID 0000-0002-7625-2648
Roman FischerDiscovery Proteomics Facility, Nuffield Department of Medicine, University of Oxford, UK.ORCID 0000-0002-9715-5951
Terry K SmithBiomedical Science Research Centre, School of Biology, University of St Andrews, St Andrews, UK.ORCID 0000-0003-1994-2009
Ludovic AutinScripps Research Institute, Torrey Pines Rd, La Jolla, CA, USA.ORCID 0000-0002-2197-191X
David BhellaMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID 0000-0003-2096-8310
Edward HutchinsonMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID 0000-0003-3673-9096

Funding

Structural Biology CoreU54AI170855 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Stefan G Sarafianos, Bruce Edward Torbett · 2022 to 2026
$36.7M
Modeling and Interacting with the Visible Molecular CellR01GM120604 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI AUTIN, LUDOVIC · 2016 to 2025
$4.2M
NIAID NIH HHS U54 AI170855NIGMS NIH HHS R01 GM120604
6 · The paper itself

Abstract

Influenza A viruses (IAV) are clinically important pathogens that cause seasonal epidemics and pandemics in humans. IAV produce pleomorphic, enveloped virions, which can range from a spherical or bacilliform morphology, the predominant form in the most commonly studied laboratory strains, to long filamentous virions which are characteristic of clinical and veterinary isolates. Understanding the structure and function of filamentous virions is crucial for clarifying their role in viral persistence and immune evasion, and for informing the development of therapeutics that target their entry and/or egress pathways. Structural characterisation of influenza virions is challenging however owing to their fragility, heterogeneity and compared to most virus particles, unusually large size. Here, we combined structural and compositional approaches with integrative modelling to define the complete molecular architecture of influenza virions. In doing so we provide the first description of distinctive structural features of IAV filaments, including the selective incorporation of lipids, specific enrichment of viral and host proteins, and a viral cytoskeleton including a secondary helical layer within the viral capsid and extended fibrils of cofilactin. Collectively our findings suggest an important regulatory role for cofilactin in driving filament morphogenesis and provide important insights into the organisation and composition of IAV filamentous virions.

Identifiers

PMID41959045
PMCPMC13060464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.